Business directory profile

Uniqure N.v.


uniqure.com


Access Company Details

Uniqure N.v.

Office phone +31 20 240 ****
Get Phone Number

Homepage http://www.uniqure.com
LinkedIn Profile https://linkedin.com/company/amste***lar-thera***
HQ Location Netherlands , Noord-Holland, Amsterdam
Meibergdreef 61 Amsterdam, 1105BA Netherlands
Last Update 2018-01-01
Manage your Business
uniQure N.V., a gene therapy company, engages in the discovery, development, and commercialization of gene therapies in the Netherlands. The company develops AMT-060, which is in Phase I/II clinical trial to treat hemophilia B; AMT-061, a gene therapy that is in Phase III clinical trial for the treatment of hemophilia; and AMT-126, a gene therapy for the treatment of congestive heart failure and AMT-130 to treat huntington's disease. The company has collaboration and license agreements with Bristol-Myers Squibb Company, 4D Molecular Therapeutics, Synpromics. uniQure N.V. was founded in 1998 and is headquartered in Amsterdam, the Netherlands.



Biotechnology and Molecular Biology Research

Companies in the biotechnology and molecular biology industry use advanced technologies to research and develop products that are used to diagnose or treat diseases. This also involves gene manipulation which can be used to create new medicines or vaccines.

Career Opportunities at Uniqure N.v.



Employees of 'Uniqure N.v.'





Details of Uniqure

Stock information
QURE NMS
Founded in
1998
Services
gece nsoredc
ace
gcensor
lce
Industry
Biotechnology and Molecular Biology Research
Company Type
Private Company
Enterprise Size
censo redcens
Headquartered
Netherlands, Noord-Holland, Amsterdam
Website
http://www.uniqure.com


Related Companies and Competitors




Access All Contact Details
Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive to ensure that the information is accurate and up-to-date, we cannot guarantee its completeness or accuracy. We do not endorse or guarantee the products or services of any company or individual listed.